Unchanged safety outcomes in deep brain stimulation surgery for Parkinson disease despite a decentralization of care

Clinical article

Restricted access

Object

Early work on deep brain stimulation (DBS) surgery, when procedures were mostly carried out in a small number of high-volume centers, demonstrated a relationship between surgical volume and procedural safety. However, over the past decade, DBS has become more widely available in the community rather than solely at academic medical centers. The authors examined the Nationwide Inpatient Sample (NIS) to study the safety of DBS surgery for Parkinson disease (PD) in association with this change in practice patterns.

Methods

The NIS is a stratified sample of 20% of all patient discharges from nonfederal hospitals in the United States. The authors identified patients with a primary diagnosis of PD (332.0) and a primary procedure code for implantation/replacement of intracranial neurostimulator leads (02.93) who underwent surgery between 2002 and 2009. They analyzed outcomes using univariate and hierarchical, logistic regression analyses.

Results

The total number of DBS cases remained stable from 2002 through 2009. Despite older and sicker patients undergoing DBS, procedural safety (rates of non-home discharges, complications) remained stable. Patients at low-volume hospitals were virtually indistinguishable from those at high-volume hospitals, except that patients at low-volume hospitals had slightly higher comorbidity scores (0.90 vs 0.75, p < 0.01). Complications, non-home discharges, length of hospital stay, and mortality rates did not significantly differ between low- and high-volume hospitals when accounting for hospital-related variables (caseload, teaching status, location).

Conclusions

Prior investigations have demonstrated a robust volume-outcome relationship for a variety of surgical procedures. However, the present study supports safety of DBS at smaller-volume centers. Prospective studies are required to determine whether low-volume centers and higher-volume centers have similar DBS efficacy, a critical factor in determining whether DBS is comparable between centers.

Abbreviations used in this paper:CI = confidence interval; DBS = deep brain stimulation; HCUP = Healthcare Cost and Utilization Project; ICD-9 = International Classification of Diseases, 9th edition; LOS = length of stay; NIS = Nationwide Inpatient Sample; OR = odds ratio; PD = Parkinson disease.

Article Information

Address correspondence to: Robert A. McGovern, M.D., Department of Neurological Surgery, Neurological Institute, Columbia University Medical Center, 710 West 168th St., New York, NY 10032. email: ram2140@columbia.edu.

Please include this information when citing this paper: published online September 27, 2013; DOI: 10.3171/2013.8.JNS13475.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    Total number of discharges for patients treated with DBS for PD between 2002 and 2009.

  • View in gallery

    Mean age in years and modified comorbidity score of patients discharged after DBS surgery for PD between 2002 and 2009.

  • View in gallery

    Yearly caseload at the hospital of discharge for patients treated with with DBS for PD between 2002 and 2009.

  • View in gallery

    Percentage of non-home discharges for patients treated with DBS for PD between 2002 and 2009. Non-home discharges exclude routine discharges and discharges including home health care.

  • View in gallery

    Percentage of discharges for patients treated with DBS for PD with any complication between 2002 and 2009. Complications include hematoma complicating a procedure, hemorrhage, infarction, infectious complications related to a mechanical device, mechanical complications related to a neurological device, lead removal, and urinary tract infections.

  • View in gallery

    Average LOS for patients discharged after DBS surgery for PD between 2002 and 2009.

References

1

Ahlskog JEMuenter MD: Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature. Mov Disord 16:4484582001

2

Bardach NSZhao SGress DRLawton MTJohnston SC: Association between subarachnoid hemorrhage outcomes and number of cases treated at California hospitals. Stroke 33:185118562002

3

Barker FG II: Craniotomy for the resection of metastatic brain tumors in the U.S., 1988–2000: decreasing mortality and the effect of provider caseload. Cancer 100:99910072004

4

Barker FG IIAmin-Hanjani SButler WEOgilvy CSCarter BS: In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996–2000: the effect of hospital and surgeon volume. Neurosurgery 52:99510092003

5

Barker FG IICurry WT JrCarter BS: Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro Oncol 7:49632005

6

Barker FG IIKlibanski ASwearingen B: Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88:470947192003

7

Berman MFSolomon RAMayer SAJohnston SCYung PP: Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke 34:220022072003

8

Birkmeyer JDSiewers AEFinlayson EVStukel TALucas FLBatista I: Hospital volume and surgical mortality in the United States. N Engl J Med 346:112811372002

9

Birkmeyer JDStukel TASiewers AEGoodney PPWennberg DELucas FL: Surgeon volume and operative mortality in the United States. N Engl J Med 349:211721272003

10

Cebul RDSnow RJPine RHertzer NRNorris DG: Indications, outcomes, and provider volumes for carotid endarterectomy. JAMA 279:128212871998

11

Chernov MF: The impact of provider volume on mortality after intracranial tumor resection and outcome and cost of craniotomy performed to treat tumors in regional academic referral centers. Neurosurgery 54:102710282004. (Letter)

12

Cowan JA JrDimick JBLeveque JCThompson BGUpchurch GR JrHoff JT: The impact of provider volume on mortality after intracranial tumor resection. Neurosurgery 52:48542003

13

Cowan JA JrDimick JBThompson BGStanley JCUpchurch GR Jr: Surgeon volume as an indicator of outcomes after carotid endarterectomy: an effect independent of specialty practice and hospital volume. J Am Coll Surg 195:8148212002

14

Cowan JA JrDimick JBWainess RMUpchurch GR JrThompson BG: Outcomes after cerebral aneurysm clip occlusion in the United States: the need for evidence-based hospital referral. J Neurosurg 99:9479522003

15

Cross DT IIITirschwell DLClark MATuden DDerdeyn CPMoran CJ: Mortality rates after subarachnoid hemorrhage: variations according to hospital case volume in 18 states. J Neurosurg 99:8108172003

16

Curry WTMcDermott MWCarter BSBarker FG II: Craniotomy for meningioma in the United States between 1988 and 2000: decreasing rate of mortality and the effect of provider caseload. J Neurosurg 102:9779862005

17

de Lau LMLBreteler MMB: Epidemiology of Parkinson's disease. Lancet Neurol 5:5255352006

18

Deuschl GSchade-Brittinger CKrack PVolkmann JSchäfer HBötzel K: A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 355:8969082006

19

Dudley RAJohansen KLBrand RRennie DJMilstein A: Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA 283:115911662000

20

Elixhauser ASteiner CHarris DRCoffey RM: Comorbidity measures for use with administrative data. Med Care 36:8271998

21

Eskandar ENFlaherty ACosgrove GRShinobu LABarker FG II: Surgery for Parkinson disease in the United States, 1996 to 2000: practice patterns, short-term outcomes, and hospital charges in a nationwide sample. J Neurosurg 99:8638712003

22

Follett KAWeaver FMStern MHur KHarris CLLuo P: Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 362:207720912010

23

Gologorsky YBen-Haim SMoshier ELGodbold JTagliati MWeisz D: Transgressing the ventricular wall during subthalamic deep brain stimulation surgery for Parkinson disease increases the risk of adverse neurological sequelae. Neurosurgery 69:2943002011

24

Hannan ELPopp AJFeustel PHalm EBernardini GWaldman J: Association of surgical specialty and processes of care with patient outcomes for carotid endarterectomy. Stroke 32:289028972001

25

Hariz MI: Complications of deep brain stimulation surgery. Mov Disord 17:Suppl 3S162S1662002

26

Hattori NKatayama YAbe T: Case volume does not correlate with outcome after cerebral aneurysm clipping: a nationwide study in Japan. Neurol Med Chir (Tokyo) 47:951012007

27

Higashida RTLahue BJTorbey MTHopkins LNLeip EHanley DF: Treatment of unruptured intracranial aneurysms: a nationwide assessment of effectiveness. AJNR Am J Neuroradiol 28:1461512007

28

Hoh BLRabinov JDPryor JCCarter BSBarker FG II: Inhospital morbidity and mortality after endovascular treatment of unruptured intracranial aneurysms in the United States, 1996–2000: effect of hospital and physician volume. AJNR Am J Neuroradiol 24:140914202003

29

Holt PJPoloniecki JDLoftus IMThompson MM: Metaanalysis and systematic review of the relationship between hospital volume and outcome following carotid endarterectomy. Eur J Vasc Endovasc Surg 33:6456512007

30

Johnston SC: Effect of endovascular services and hospital volume on cerebral aneurysm treatment outcomes. Stroke 31:1111172000

31

Johnston SCDudley RAGress DROno L: Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals. Neurology 52:179918051999

32

Johnston SCZhao SDudley RABerman MFGress DR: Treatment of unruptured cerebral aneurysms in California. Stroke 32:5976052001

33

Karp HRFlanders WDShipp CCTaylor BMartin D: Carotid endarterectomy among Medicare beneficiaries: a statewide evaluation of appropriateness and outcome. Stroke 29:46521998

34

Kassell NFTorner JCHaley EC JrJane JAAdams HPKongable GL: The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 73:18361990

35

Killeen SDAndrews EJRedmond HPFulton GJ: Provider volume and outcomes for abdominal aortic aneurysm repair, carotid endarterectomy, and lower extremity revascularization procedures. J Vasc Surg 45:6156262007

36

Kucey DSBowyer BIron KAustin PAnderson GTu JV: Determinants of outcome after carotid endarterectomy. J Vasc Surg 28:105110581998

37

Long DMGordon TBowman HEtzel ABurleyson GBetchen S: Outcome and cost of craniotomy performed to treat tumors in regional academic referral centers. Neurosurgery 52:105610652003

38

Martin AJLarson PSOstrem JLSootsman WKTalke PWeber OM: Placement of deep brain stimulator electrodes using real-time high-field interventional magnetic resonance imaging. Magn Reson Med 54:110711142005

39

Nazarian SMYenokyan GThompson REGriswold MEChang DCPerler BA: Statistical modeling of the volume-outcome effect for carotid endarterectomy for 10 years of a statewide database. J Vasc Surg 48:3433502008

40

Nuño MMukherjee DCarico CElramsisy AVeeravagu ABlack KL: The effect of centralization of caseload for primary brain tumor surgeries: trends from 2001–2007. Acta Neurochir (Wien) 154:134313502012

41

O'Neill LLanska DJHartz A: Surgeon characteristics associated with mortality and morbidity following carotid endarterectomy. Neurology 55:7737812000

42

Pierot LSpelle LVitry F: Similar safety in centers with low and high volumes of endovascular treatments for unruptured intracranial aneurysms: evaluation of the analysis of treatment by endovascular approach of nonruptured aneurysms study. AJNR Am J Neuroradiol 31:101010142010

43

Rezai ARKopell BHGross REVitek JLSharan ADLimousin P: Deep brain stimulation for Parkinson's disease: surgical issues. Mov Disord 21:Suppl 14S197S2182006

44

Schuepbach WMRau JKnudsen KVolkmann JKrack PTimmermann L: Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 368:6106222013

45

Smith ERButler WEBarker FG II: Craniotomy for resection of pediatric brain tumors in the United States, 1988 to 2000: effects of provider caseloads and progressive centralization and specialization of care. Neurosurgery 54:5535652004

46

Solomon RAMayer SATarmey JJ: Relationship between the volume of craniotomies for cerebral aneurysm performed at New York state hospitals and in-hospital mortality. Stroke 27:13171996

47

Tanner CMGoldman SM: Epidemiology of Parkinson's disease. Neurol Clin 14:3173351996

48

Taylor BHarries PBullock R: Factors affecting outcome after surgery for intracranial aneurysm in Glasgow. Br J Neurosurg 5:5916001991

49

Taylor CLYuan ZSelman WRRatcheson RARimm AA: Mortality rates, hospital length of stay, and the cost of treating subarachnoid hemorrhage in older patients: institutional and geographical differences. J Neurosurg 86:5835881997

50

Weaver FMFollett KStern MHur KHarris CMarks WJ Jr: Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301:63732009

51

Wennberg DELucas FLBirkmeyer JDBredenberg CEFisher ES: Variation in carotid endarterectomy mortality in the Medicare population: trial hospitals, volume, and patient characteristics. JAMA 279:127812811998

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 95 95 21
Full Text Views 135 135 2
PDF Downloads 160 160 5
EPUB Downloads 0 0 0

PubMed

Google Scholar